Cost‐effectiveness analysis of 9‐valent human papillomavirus vaccine combined with screening for cervical cancer in Japan
Increasing the coverage of the 9-valent HPV vaccination and cervical screening is cost-effective in Japan.
Authors
- Shotaro Aso (ORCID: https://orcid.org/0000-0002-7804-2433)
- Naohiro Takamoto (ORCID: https://orcid.org/0000-0002-2061-9017)
- Takaaki Konishi
- R. Ishida (ORCID: https://orcid.org/0009-0000-7476-4976)
- Kiyohide Fushimi (ORCID: https://orcid.org/0000-0002-1894-0290)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
Institutions
- Tokyo Medical and Dental University (JP)
- University of Tokyo Health Sciences (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1002/ijgo.16125
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39